Novo Nordisk Expands Affordability Offering with $35 Insulin Program called MyInsulinRx
PLAINSBORO, N.J., September 13, 2023 – Effective today, a $35.00 insulin option called MyInsulinRxTM is available from Novo Nordisk Inc for eligible patients. The program builds on existing Novo Nordisk insulin affordability options and is...
Read more »